ONCY - ONCOLYTICS BIOTECH INC

QQQ $ 629.08 $ 10.99 (1.78 %)

DIA $ 475.50 $ 3.14 (0.66 %)

SPY $ 685.64 $ 7.99 (1.18 %)

TLT $ 91.89 $ 0.31 (0.34 %)

GLD $ 366.80 $ -10.51 (-2.78 %)

Previous Close

$ 1.21

Open

$ 1.21

Bid

$ 1.21 x 18

Ask

$ 1.23 x 2,966

Day's Range

$ 1.16 - $ 1.22

52 Week Range

$ 0.33 - $ 1.51

Volume

615,380

Average Volume

Market Cap

96.82M

Beta (5Y Monthly)

$ 1.07

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oncolytics Biotech Plans Move From Canada ...
10/20/2025 13:12:30

Oncolytics Biotech® Inc. (NASDAQ:ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company ...

Oncolytics Biotech Files For Common Stock ...
10/17/2025 20:49:50

- SEC Filing

12 Health Care Stocks Moving In Friday's P...
10/10/2025 12:07:59

Oncolytics Biotech Updates GOBLET Trial: P...
09/16/2025 11:06:22

12 Health Care Stocks Moving In Monday's P...
09/15/2025 12:10:36

Oncolytics Biotech Reports Pelareorep Boos...
09/08/2025 11:10:21

Oncolytics Biotech® Inc. (NASDAQ:ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company ...

Oncolytics Updates Pelareorep Safety Analy...
09/02/2025 13:13:30

Oncolytics Biotech Files For Mixed Shelf O...
08/22/2025 21:25:28

-SEC Filing

Lake Street Initiates Coverage On Oncolyti...
08/13/2025 15:00:20

Lake Street analyst Chad Messer initiates coverage on Oncolytics Biotech (NASDAQ:ONCY) with a Buy rating and announces Price...

Oncolytics Biotech Q2 EPS $(0.05) Beats $(...
08/08/2025 13:09:18

Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(...

Oncolytics Biotech To Voluntarily Delist F...
08/08/2025 13:01:51

Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC) ("Oncolytics" or the "Company"), a clinical-stage immunotherap...

Earnings Scheduled For August 8, 2025
08/08/2025 08:32:13

What to Expect from Oncolytics Biotech's E...
08/07/2025 16:08:15

Oncolytics Biotech Initiated Regulatory Di...
07/29/2025 12:32:49

Clear regulatory path and strong survival data in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) support accele...

Oncolytics Biotech Regains Nasdaq Compliance
07/22/2025 19:34:30

Oncolytics Biotech Presents Aggregated Tra...
07/16/2025 12:32:01

Integrated biomarker analyses confirm viral replication, interferon signaling, and a surge in tumor-infiltrating lymphocytes af...

Oncolytics Names Jared Kelly CEO, Wayne Pi...
06/11/2025 11:07:25

Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC), a leading clinical-stage company specializing in immunotherapy for oncology, ...

why-e2open-shares-are-trading-higher-by-25-here-are-20-stocks-moving-premarket

Why E2open Shares Are Trading Higher By 25...
05/27/2025 09:16:35

Oncolytics Biotech To Present New Data Fro...
05/23/2025 11:05:06

Pelareorep initiates a pro-inflammatory tumor microenvironment (TME) and induces innate and adaptive immune responsesNew analys...

HC Wainwright & Co. Reiterates Buy on Onco...
05/21/2025 11:12:23

HC Wainwright & Co. analyst Patrick Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $5 pri...